Lima MR, Farias LABG, da Ponte MF, Furtado LET de A. Self-Limited Cytomegalovirus Infection During Natalizumab Treatment for Multiple Sclerosis. EJCRIM [Internet]. 2019 Feb. 1 [cited 2026 Nov. 3];6(2). Available from: https://ejcrim.com/index.php/ejcrim/article/view/1046